AI assistant
Sending…
CONMED Corp — Director's Dealing 2012
Mar 15, 2012
31971_dirs_2012-03-15_5c06a1f9-f541-4591-ae59-d7bc3c937edd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-03-13
Reporting Person: CORASANTI EUGENE R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-13 | Common Stock | M | 112500 | $25.89 | Acquired | 180303 | Direct |
| 2012-03-13 | Common Stock | S | 112500 | $29.1537 | Disposed | 67803 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-13 | Options To Purchase Common Stock | $25.89 | M | 112500 | Disposed | 2012-05-14 | Common Stock (112500) | Direct |
Footnotes
F1: 5 year vesting schedule, 20% vest each year starting 5/14/2003
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.10 to $29.291. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7